Evidence map›Paper›PMID 26369580›Full record

ArticleJournal of bacteriology2015

GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis.

Gaëlle S Kolly, Raju Mukherjee, Emöke Kilacsková, Luciano A Abriata, Mahé Raccaud, Jaroslav Blaško, Claudia Sala, Matteo Dal Peraro, Katarína Mikušová, Stewart T Cole

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Berberine, the major bioactive compound frombioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Anti-tuberculosis drug developmentFrontiers in microbiology · 2022
    Review
  10. International journal of molecular sciences · 2021
    Article
  11. Review
  12. Review
  13. GtcA is required for LTA glycosylation inCell surface (Amsterdam, Netherlands) · 2020
    Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Gaëlle S KollyMore Medicines for Tuberculosis (MM4TB) Consortium‡ Ecole Polytechnique Fédérale de Lausanne, Global Health Institute, Lausanne, Switzerland.
Raju MukherjeeMore Medicines for Tuberculosis (MM4TB) Consortium‡ Ecole Polytechnique Fédérale de Lausanne, Global Health Institute, Lausanne, Switzerland.
Emöke KilacskováMore Medicines for Tuberculosis (MM4TB) Consortium‡ Comenius University in Bratislava, Faculty of Natural Sciences, Department of Biochemistry, Bratislava, Slovak Republic.
Luciano A AbriataLaboratory for Biomolecular Modeling, Ecole Polytechnique Fédérale de Lausanne and Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Mahé RaccaudEcole Polytechnique Fédérale de Lausanne, Global Health Institute, Lausanne, Switzerland.
Jaroslav BlaškoMore Medicines for Tuberculosis (MM4TB) Consortium‡ Comenius University in Bratislava, Faculty of Natural Sciences, Institute of Chemistry, Bratislava, Slovak Republic.
Claudia SalaMore Medicines for Tuberculosis (MM4TB) Consortium‡ Ecole Polytechnique Fédérale de Lausanne, Global Health Institute, Lausanne, Switzerland.
Matteo Dal PeraroLaboratory for Biomolecular Modeling, Ecole Polytechnique Fédérale de Lausanne and Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Katarína MikušováMore Medicines for Tuberculosis (MM4TB) Consortium‡ Comenius University in Bratislava, Faculty of Natural Sciences, Department of Biochemistry, Bratislava, Slovak Republic.
Stewart T ColeMore Medicines for Tuberculosis (MM4TB) Consortium‡ Ecole Polytechnique Fédérale de Lausanne, Global Health Institute, Lausanne, Switzerland stewart.cole@epfl.ch.
Global Fund to Fight AIDS, Tuberculosis and Malaria · CHÉcole Polytechnique Fédérale de Lausanne · CHSIB Swiss Institute of Bioinformatics · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledMycobacterium tuberculosis possesses a thick and highly hydrophobic cell wall principally composed of a mycolyl-arabinogalactan-peptidoglycan complex, which is critical for survival and virulence. DprE1 is a well-characterized component of decaprenyl-phospho-ribose epimerase, which produces decaprenyl-phospho-arabinose (DPA) for the biosynthesis of mycobacterial arabinans. Upstream of dprE1 lies rv3789, which encodes a short transmembrane protein of the GtrA family, whose members are often involved in the synthesis of cell surface polysaccharides. We demonstrate that rv3789 and dprE1 are cotranscribed from a common transcription start site situated 64 bp upstream of rv3789. Topology mapping revealed four transmembrane domains in Rv3789 and a cytoplasmic C terminus consistent with structural models built using analysis of sequence coevolution. To investigate its role, we generated an unmarked rv3789 deletion mutant in M. tuberculosis. The mutant was characterized by impaired growth and abnormal cell morphology, since the cells were shorter and more swollen than wild-type cells. This phenotype likely stems from the decreased incorporation of arabinan into arabinogalactan and was accompanied by an accumulation of DPA. A role for Rv3789 in arabinan biosynthesis was further supported by its interaction with the priming arabinosyltransferase AftA, as demonstrated by a two-hybrid approach. Taken together, the data suggest that Rv3789 does not act as a DPA flippase but, rather, recruits AftA for arabinogalactan biosynthesis. IMPORTANCE: Upstream of the essential dprE1 gene, encoding a key enzyme of the decaprenyl phospho-arabinose (DPA) pathway, lies rv3789, coding for a short transmembrane protein of unknown function. In this study, we demonstrated that rv3789 and dprE1 are cotranscribed from a common transcription start site located 64 bp upstream of rv3789 in M. tuberculosis. Furthermore, the deletion of rv3789 led to a reduction in arabinan content and to an accumulation of DPA, confirming that Rv3789 plays a role in arabinan biosynthesis. Topology mapping, structural modeling, and protein interaction studies suggest that Rv3789 acts as an anchor protein recruiting AftA, the first arabinosyl transferase. This investigation provides deeper insight into the mechanism of arabinan biosynthesis in mycobacteria.

Indexed as

Aldehyde OxidoreductasesAmino Acid SequenceArabinoseBacterial ProteinsBase SequenceGalactansMolecular Sequence DataMycobacterium tuberculosisSequence AlignmentTerpenesAldehyde OxidoreductasesarabinogalactanArabinoseBacterial Proteinsdecaprenyl-P-arabinoseGalactansglutamyl tRNA reductaseTerpenes

Identifiers

PMID26369580
PMCPMC4626892
OpenAlexW2175184680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.